Cardiac physiology and pharmacology focus on the functions of the heart and the effects of various drugs on these functions. Recent research has explored the roles of different receptors and ...

Angiotensin receptor blockers (ARBs) are the preferred drug in patients who are unable ... It is also indicated to reduce risk for cardiovascular events in patients with coronary artery disease ...

Scientists have long searched for drugs that can prevent VF, but most have failed clinical trials because of serious side ...

Fewer than half of heart patients from 17 countries who could benefit from beneficial drugs are taking them, researchers ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves ...

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...

Our faculty pursue a variety of scientific interests in the areas of neurological disorders, cancer therapeutics, pain, cardiovascular ... graduate programs in Pharmacology and Physiology (MS and PhD) ...

Specifically, we will address current knowledge, controversies and emerging evidence in relation to cardiovascular (CV) health of athletes taking drugs. Further, we delimit our discussion to the CV ...

The global drug discovery services market is set for remarkable growth, with its valuation projected to surge from USD 19.7 ...